ArticleFrontiers in oncology2026

Circulating cell-free DNA as an integrative biomarker in breast cancer: correlation with molecular subtypes, mutation status, and treatment response.

Ranjana Solanki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.